Works about GLYCOGEN synthase kinase

Results: 835
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19

    GSK3 inhibition improves skeletal muscle function and whole-body metabolism in male mouse models of Duchenne muscular dystrophy.

    Published in:
    Nature Communications, 2024, v. 15, n. 1, p. 1, doi. 10.1038/s41467-024-53886-y
    By:
    • Marcella, Bianca M.;
    • Hockey, Briana L.;
    • Braun, Jessica L.;
    • Whitley, Kennedy C.;
    • Geromella, Mia S.;
    • Baranowski, Ryan W.;
    • Watson, Colton J. F.;
    • Silvera, Sebastian;
    • Hamstra, Sophie I.;
    • Wasilewicz, Luc J.;
    • Crozier, Robert W. E.;
    • Marais, Amélie A. T.;
    • Kim, Kun Ho;
    • Lee, Gabsang;
    • Vandenboom, Rene;
    • Roy, Brian D.;
    • MacNeil, Adam J.;
    • MacPherson, Rebecca E. K.;
    • Fajardo, Val A.
    Publication type:
    Article
    20
    21
    22
    23
    24
    25
    26
    27
    28
    29
    30
    31

    In silico docking and comparative ADMET profile of different glycogen synthase kinase 3 beta inhibitors as the potential leads for the development of anti-Alzheimer drug therapy.

    Published in:
    Journal of Advanced Pharmaceutical Technology & Research, 2020, v. 11, n. 4, p. 194, doi. 10.4103/japtr.JAPTR_178_19
    By:
    • Prajapat, Manisha;
    • Sarma, Phulen;
    • Shekhar, Nishant;
    • Kaur, Hardeep;
    • Singh, Sanjay;
    • Kumar, Subodh;
    • Kaur, Harpinder;
    • Mahendiratta, Saniya;
    • Sharma, Amit;
    • Kaur, Sukhmandeep;
    • Mahalmani, Vidya;
    • Medhi, Bikash
    Publication type:
    Article
    32
    33
    34
    35
    36
    37
    38
    39
    40
    41
    42
    43
    44
    45
    46
    47
    48
    49
    50